Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Spotlight on circulating tumour cells

MBCC 12

16 - 18 Jun 2010

Published: 3 Sep 2010

Views: 7955

Rating:

Save

Dr Richard Cote - University of Miami, Miami, USA

Dr Richard Cote - University of Miami, Miami, USA, speaking at the 12th Milan Breast Cancer Conference, June 2010: Circulating Tumour Cells. Download the slides here.

Related Videos

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

Precision oncology: Present and future in breast cancer

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Precision oncology: Present and future in breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

Metastatic bone disease: Importance of bone-targeted agents

Dr Alastair Greystoke - Newcastle University, Newcastle, UK and Prof Robert...

Metastatic bone disease: Importance of bone-targeted agents ( Dr Alastair Greystoke - Newcastle University, Newcastle, UK and Prof Robert Coleman - The University of Sheffield, Sheffield, UK )

Treatment sequencing for patients with mCRPC

Prof Axel Merseburger and Prof Stéphane Oudard

Treatment sequencing for patients with mCRPC ( Prof Axel Merseburger and Prof Stéphane Oudard )

Choosing Wisely in implementing prevention, screening and early detection...

Dr Gad Murenzi - Rwanda Military Hospital, Kigali, Rwanda

Choosing Wisely in implementing prevention, screening and early detection programs in Africa ( Dr Gad Murenzi - Rwanda Military Hospital, Kigali, Rwanda )

Overview of the management of HER2-low breast cancer patients

Prof Hope Rugo - University of California San Francisco, San Francisco, USA

Overview of the management of HER2-low breast cancer patients ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )

Evidence-based approach to lymph node assessment and targeted axillary...

Prof Jessica Leung - MD Anderson Cancer Center, Houston, USA

Evidence-based approach to lymph node assessment and targeted axillary dissection ( Prof Jessica Leung - MD Anderson Cancer Center, Houston, USA )

Treatment decision guided by CTC count may improve long-term outcomes for mBC

Prof Jean-Yves Pierga - Institut Curie, Paris, France

Treatment decision guided by CTC count may improve long-term outcomes for mBC ( Prof Jean-Yves Pierga - Institut Curie, Paris, France )

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan

Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston...

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan ( Prof Naoto Ueno - The University of Texas MD Anderson Cancer Center, Houston, USA )

More from ecancer